Yamaji K - Search Results

1

Efficacy of cytapheresis for remission induction and dermatological manifestations of ulcerative colitis.

Nomura O, Osada T, Shibuya T, Ishikawa D, Haga K, Kodani T, Sakamoto N, Ogihara T, Yamaji K, Watanabe S. Nomura O, et al. Among authors: yamaji k. J Clin Apher. 2018 Feb;33(1):21-28. doi: 10.1002/jca.21555. Epub 2017 Jun 5. J Clin Apher. 2018. PMID: 28581039

2

Efficacy of cytapheresis for induction therapy and extra-intestinal skin manifestations of ulcerative colitis.

Shibuya T, Nomura O, Nomura K, Haraikawa M, Haga K, Ishikawa D, Osada T, Yamaji K, Ikeda S, Nagahara A. Shibuya T, et al. Among authors: yamaji k. Ther Apher Dial. 2022 Jun;26(3):522-528. doi: 10.1111/1744-9987.13823. Epub 2022 Mar 10. Ther Apher Dial. 2022. PMID: 35247233

3

Involvement of Mucosal-associated Invariant T cells in Ankylosing Spondylitis.

Hayashi E, Chiba A, Tada K, Haga K, Kitagaichi M, Nakajima S, Kusaoi M, Sekiya F, Ogasawara M, Yamaji K, Tamura N, Takasaki Y, Miyake S. Hayashi E, et al. Among authors: yamaji k. J Rheumatol. 2016 Sep;43(9):1695-703. doi: 10.3899/jrheum.151133. Epub 2016 Jul 1. J Rheumatol. 2016. PMID: 27370879

4

Current topics on cytapheresis technologies.

Yamaji K, Tsuda H, Hashimoto H. Yamaji K, et al. Ther Apher. 2001 Aug;5(4):287-92. doi: 10.1046/j.1526-0968.2001.00358.x. Ther Apher. 2001. PMID: 11724514 Review.

5

Reduction in bradykinin generation during leukocytapheresis using novel cellsorba(TM) CS-180S: Effects of changing the filling solution.

Yamada R, Kusaoi M, Murayama G, Yasui M, Hishinuma R, Nemoto T, Hohtatsu K, Kageyama M, Kawamoto T, Sugimoto K, Sekiya F, Kon T, Ogasawara M, Kempe K, Yamaji K, Tsuda H, Takasaki Y. Yamada R, et al. Among authors: yamaji k. J Clin Apher. 2014 Apr;29(2):90-6. doi: 10.1002/jca.21297. Epub 2013 Sep 11. J Clin Apher. 2014. PMID: 24023037

6

Combination therapy with plasma exchange and glucocorticoid may be effective for severe COVID-19 infection: A retrospective observational study.

Matsushita Y, Kusaoi M, Hiki M, Murayama G, Abe Y, Nozawa K, Takahashi K, Yamaji K, Tamura N, Naito T. Matsushita Y, et al. Among authors: yamaji k. Ther Apher Dial. 2021 Aug;25(4):390-400. doi: 10.1111/1744-9987.13656. Epub 2021 Apr 30. Ther Apher Dial. 2021. PMID: 33887110 Free PMC article.

7

Immunoadsorption plasmapheresis using a phenylalanine column as an effective treatment for lupus nephritis.

Sugimoto K, Yamaji K, Yang KS, Kanai Y, Tsuda H, Hashimoto H. Sugimoto K, et al. Among authors: yamaji k. Ther Apher Dial. 2006 Apr;10(2):187-92. doi: 10.1111/j.1744-9987.2006.00362.x. Ther Apher Dial. 2006. PMID: 16684222

8

Long-term clinical outcomes of synchronized therapy with plasmapheresis and intravenous cyclophosphamide pulse therapy in the treatment of steroid-resistant lupus nephritis.

Yamaji K, Kim YJ, Tsuda H, Takasaki Y. Yamaji K, et al. Ther Apher Dial. 2008 Aug;12(4):298-305. doi: 10.1111/j.1744-9987.2008.00591.x. Ther Apher Dial. 2008. PMID: 18789117

9

Current topics on therapeutic apheresis.

Yamaji K. Yamaji K. J Artif Organs. 2010 Jul;13(2):73-6. doi: 10.1007/s10047-010-0501-4. Epub 2010 Apr 3. J Artif Organs. 2010. PMID: 20364285 Review.

10

Safety and efficacy of the leukocytapheresis procedure in eighty-five patients with rheumatoid arthritis.

Kitagaichi M, Kusaoi M, Tsukahara T, Murayama G, Nemoto T, Sekiya F, Kon T, Ogasawara M, Kempe K, Yamaji K, Tamura N, Tsuda H, Takasaki Y. Kitagaichi M, et al. Among authors: yamaji k. Transfus Apher Sci. 2016 Oct;55(2):225-232. doi: 10.1016/j.transci.2016.07.019. Epub 2016 Jul 21. Transfus Apher Sci. 2016. PMID: 27475801 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

740 results

Search Page

Filters